All 1 tracked stories fall under one category: disruptions. IANS is most often covered alongside Active Pharmaceutical Ingredients, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 6.2.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about IANS
All 1 tracked stories fall under one category: disruptions. IANS is most often covered alongside Active Pharmaceutical Ingredients, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 6.2. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. IANS appears in 1 tracked Supply Chain story from September 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 22 Supply Chain stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering IANS. Shared-story counts are live from our verified record — not editorial picks.
A new report urges the EU to copy the UK's playbook for decoupling critical supply chains from China by shifting electronics, solar components, pharmaceuticals, and rare earths sourcing toward India. Procurement and manufacturing leaders should note the call for a phased, sector-by-sector transition rather than an abrupt switch.